Sepsis remains a major cause of death worldwide, and early biomarkers are needed for risk stratification. This study analyzed the prognostic value of NT-proBNP, fibrinogen, and vitamin D including discriminative accuracy for in-hospital mortality and correlations among these biomarkers in sepsis patients. This retrospective study included 30 adult sepsis patients admitted to a private type B hospital in West Java, Indonesia, from March to October 2024; biomarkers were measured within 24 hours after diagnosis. In-hospital mortality was 60% (18/30). Non-survivors had higher NT-proBNP (median 1130 [IQR 898–1451] vs 466 [311–613] pg/mL; p0.001), lower fibrinogen (183.7±75.1 vs 248.4±76.6 mg/dL; p=0.030), and lower vitamin D (25.8±12.7 vs 39.3±13.6 ng/mL; p=0.010) than survivors. Each biomarker discriminated in-hospital mortality (AUC 0.91 for NT-proBNP at cut-off 608 pg/mL [sensitivity 100%, specificity 75%]; AUC 0.75 for fibrinogen; AUC 0.77 for vitamin D). NT-proBNP correlated negatively with fibrinogen (ρ=-0.70) and vitamin D (ρ=-0.71); fibrinogen and vitamin D correlated strongly positively (ρ=0.89) (all p0.001, Spearman). Given the small, single-center, retrospective sample (n=30), findings should be regarded as hypothesis-generating rather than confirmatory. Combined assessment of NT-proBNP, fibrinogen, and vitamin D shows promising discriminative value for in-hospital mortality in sepsis and warrants confirmation in larger prospective studies.
Copyrights © 2026